Generic Name and Formulations:
Mupirocin 2%; oint.
Indications for BACTROBAN:
Impetigo due to S. pyogenes or S. aureus.
Adults and Children:
Apply small amount 3 times daily. May cover with gauze dressing. Reevaluate if no response within 3–5 days.
Avoid eyes. Nasal use in high-risk patients: see full labeling regarding autoinfection. Discontinue if sensitization or severe local irritation occurs. Prolonged use may result in superinfection. Pregnancy. Nursing mothers.
Nasal: avoid other concomitant nasal products.
Topical: burning, stinging, pain, itching. Nasal: headache, rhinitis, respiratory disorder, pharyngitis, taste perversion, burning/stinging, cough, pruritus; severe allergic reactions, C. difficile-associated diarrhea.
Oint—22g; Crm—15g, 30g; Nasal (single-use) (1g)—10
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- Psychological Therapies May Help Older Adults With Chronic Pain
- Traumatic Brain Injury Linked to Increased Parkinson Disease Risk in Veterans
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics